Logotype for Solvay SA

Solvay (SOLB) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Solvay SA

Q2 2026 earnings summary

29 Jul, 2026

Executive summary

  • Q2 2026 underlying net sales were €1,031 million, down 7.4% organically year-over-year, mainly due to weak soda ash pricing and the Middle East conflict disrupting operations.

  • Underlying EBITDA fell 19.5% organically to €187 million, with margin at 18.1%, impacted by the Middle East conflict and absence of a €20 million one-off gain from Q2 2025.

  • Bicarbonate and electronic-grade peroxides performed well, while soda ash export markets faced persistent pricing pressure; Coatis showed sequential improvement.

  • Transformation and cost-saving initiatives delivered tangible safety improvements and €26 million in structural cost savings in Q2 2026.

  • Free cash flow for H1 2026 was €15 million, with Q2 at €-11 million; capex for H1 reached €141 million.

Financial highlights

  • Q2 2026 underlying net sales: €1,031 million (-7.4% organic yoy); EBITDA: €187 million (-19.5% organic yoy); EBITDA margin: 18.1%.

  • H1 2026 underlying net sales: €2,028 million (-8.0% organic yoy); EBITDA: €406 million (-14.7% organic yoy); net profit: €139 million (-29.2% yoy).

  • Free cash flow to shareholders in H1 2026 was €15 million; Q2 2026 was -€11 million due to seasonality and concentrated cash outflows.

  • Capex for H1 2026 was €141 million, focused on HSE, maintenance, and energy transition projects.

  • Net debt stood at €1.8 billion at end of June 2026, leverage ratio at 2.3x, temporarily higher due to dividend payment.

Outlook and guidance

  • Full-year 2026 guidance confirmed: underlying EBITDA expected between €770 million and €850 million, including €20 million negative currency impact and €40 million transformation expenses.

  • Free cash flow to shareholders expected to be at least €200 million (net of €90 million transformation expenses), with capex around €300 million.

  • Guidance assumes the Saudi peroxides plant restarts before end of Q3 2026.

  • Cumulative structural cost savings targeted at €300 million by end of 2026.

  • Temporary transformation expenses will continue to impact free cash flow through 2027.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more